Library · Article 18 · metabolic biomarker

Triglycerides Explained:
The Plain-English Range Guide

What triglycerides actually are, what the normal range really hides, what raises and lowers them, the triglyceride-to-HDL ratio as a proxy for insulin resistance, and why even a moderately elevated triglyceride carries independent cardiovascular risk. Drawn from Module 3 of The Health Protocol Seminar.

What they are

Triglycerides are fat in transit

A triglyceride is the form in which the body stores and transports most of its fat. The molecule is made of one glycerol backbone with three fatty acids attached, hence the name. When you eat fat, most of it is packaged into triglycerides inside intestinal cells and shipped through the bloodstream as chylomicrons to be either burned for energy or stored. When you eat more carbohydrate than the body needs in the moment, the liver converts the excess into triglycerides through a process called de novo lipogenesis and exports them into circulation packaged in very-low-density lipoprotein, or VLDL.[1]

This is the first thing that surprises most people about triglycerides. The number on a lipid panel reflects fat in transit through the blood, but a large fraction of that fat was assembled by the liver out of carbohydrate, not eaten as fat in the first place. Fructose is the clearest example, because it is metabolized almost entirely in the liver and is a particularly potent driver of de novo lipogenesis. In a controlled ten-week study, overweight adults who drank fructose-sweetened beverages supplying a quarter of their energy increased de novo lipogenesis, developed dyslipidemia, and lost insulin sensitivity, while those drinking glucose-sweetened beverages did not, even though both groups gained similar weight.[4] This is why a diet high in refined carbohydrate and added sugar reliably elevates fasting triglycerides even in the absence of meaningful fat consumption, and why the low-fat era, which replaced fat with refined starch and sugar, so often produced rising triglycerides rather than falling ones.

The numbers, in plain English

What the normal range actually says

A standard fasting lipid panel categorizes triglycerides into roughly these bands (units are mg/dL, as used in the United States):

Outside the United States, the same panel is usually reported in mmol/L. The conversion factor is 0.0113. So 150 mg/dL is approximately 1.7 mmol/L. The bands are otherwise identical.

There is an important nuance the "normal" label hides. A triglyceride number under 150 mg/dL is the official cutoff for "normal," but the metabolic literature has converged on a much more demanding optimal range. A fasting triglyceride below 100 mg/dL (about 1.1 mmol/L) is the genuine optimum.[1] Numbers between 100 and 150 are technically normal but increasingly recognized as a sign of early insulin resistance: in overweight adults, a fasting triglyceride at or above roughly 130 mg/dL is one of the single most useful lipid-panel markers for identifying insulin resistance.[5] Numbers between 75 and 100 are characteristic of metabolically healthy populations. Numbers below 75 are common in plant-based eaters, in regular fasters, and in trained endurance athletes.

This matters because a person told their triglycerides are "normal" at 140 mg/dL may be reassured at the moment they should be informed. The lab range is a population threshold for clinical concern, not a target for health.

Why this number is so informative

Triglycerides as a metabolic mirror

Of all the lines on a standard lipid panel, fasting triglycerides are the most responsive to short-term metabolic changes and the most informative about insulin sensitivity. Total cholesterol moves slowly and is heavily influenced by genetics. LDL cholesterol is informative but takes months to shift meaningfully. HDL is slow to respond. Triglycerides, by contrast, can change measurably within weeks of an eating-pattern shift, and they track how well the body is handling carbohydrate, fat storage, and overall metabolic load.

The ratio of triglycerides to HDL cholesterol is particularly useful as a proxy for insulin resistance. In overweight adults, a triglyceride-to-HDL-cholesterol ratio at or above 3.0 (using mg/dL) identifies insulin resistance about as well as the full set of metabolic-syndrome criteria, while a low ratio is a strong sign of preserved metabolic flexibility.[5] The ratio is calculable from any standard lipid panel and is one of the most overlooked metabolic signals in routine bloodwork.

This is also why a triglyceride number is rarely abnormal on its own. The Health Protocol reads it inside a cluster: the NHLBI and the American Heart Association both note that abdominal obesity, elevated triglycerides, lower HDL cholesterol, raised blood pressure, and higher fasting glucose tend to travel together as metabolic syndrome, a pattern now estimated to affect roughly a quarter of adults worldwide.[2] The point, in the book's framing, is not to moralize body size but to recognize that central fat accumulation often signals a terrain in which insulin demand, inflammatory signaling, and cardiometabolic risk are moving in the wrong direction together. A rising triglyceride is one of the earliest readable lines in that shared drift.

What raises them, in order of impact

The inputs that move the number up

Triglycerides rise reliably in response to:

What lowers them, in order of impact

The inputs that move the number down

Triglycerides fall reliably in response to:

When triglycerides are very high

The clinical concern threshold

Between the optimal range and the very high range sits the question most people actually face: does a moderately elevated triglyceride matter for the heart? The American Heart Association's scientific statement on triglycerides and cardiovascular disease treats fasting triglycerides as an independent marker of cardiovascular risk and sets the optimal level below 100 mg/dL.[1] Pooled across twenty-nine Western prospective studies covering more than ten thousand coronary events, higher triglycerides were independently associated with coronary heart disease after adjustment for other risk factors.[7] Genetic and Mendelian-randomization studies have since moved the case from association toward causation: the triglyceride-rich remnant lipoproteins the liver exports appear to contribute directly to atherosclerotic cardiovascular disease rather than merely mark it.[8] This is the larger reason a triglyceride is worth reading carefully well before it reaches any clinical threshold.

Triglycerides above 500 mg/dL are a separate clinical category. At this level the risk of acute pancreatitis rises significantly, and aggressive intervention is warranted. People in this range should be working with a clinician. The first-line interventions remain dietary (sharp reduction of refined carbohydrate, alcohol elimination, weight loss) but may be supplemented with pharmacological options, including high-dose prescription omega-3, fibrates, and niacin in selected cases, depending on the clinical picture.[9]

For the much more common situation of triglycerides between 150 and 300 mg/dL, the framework is the same one developed throughout The Health Protocol. The number is a signal, not a disease. It is responding to the inputs the body is receiving. Change the inputs and the number changes, and the cardiovascular risk it reflects tends to change with it, especially under the kind of whole-food, plant-forward pattern with the strongest convergent evidence for coronary protection.[T1]

Where this lives in The Health Protocol

Mapped to the book

Triglycerides are part of the larger biomarker conversation in Chapters V and VI of The Health Protocol, which cover metabolic health and the cardiovascular consequences of metabolic dysfunction. The dietary patterns that move triglycerides are developed throughout Module 2 (Nourishment by Design) and the metabolic logic is the spine of Module 3 of the seminar (Metabolic Coherence).

The point is not to moralize body size. It is to recognize that central fat accumulation often signals a terrain in which insulin demand, inflammatory signaling, and cardiometabolic risk are moving in the wrong direction together.

The Health Protocol · Chapter V · p. 96

Frequently asked questions

What are triglycerides?

A triglyceride is the form in which the body stores and transports most of its fat: one glycerol backbone with three fatty acids attached. The number on a standard lipid panel reflects fat in transit through the blood, much of which the liver assembles out of excess carbohydrate rather than dietary fat. A fasting level below 100 mg/dL is the genuine optimum; the official “normal” cutoff of 150 mg/dL is a threshold for clinical concern, not a target for health.

What does a high triglyceride number tell you?

A fasting triglyceride is one of the most responsive and informative single lines on a lipid panel: it tracks insulin sensitivity, and the triglyceride-to-HDL ratio is a useful proxy for insulin resistance. Elevated triglycerides also travel with the rest of the metabolic-syndrome cluster, and even moderately raised levels are independently associated with coronary heart disease, with genetic evidence pointing toward a causal role for triglyceride-rich remnant lipoproteins.

Are high triglycerides a disease to treat?

As a signal, not a disease. The seminar treats the number as a readout of the inputs the body is receiving (refined carbohydrate and added sugar, alcohol, sedentary time, sleep, and visceral fat) and works on those inputs. Reducing refined carbohydrate and sugar is the single highest-leverage change; plant-forward eating, time-restricted eating, daily movement, and where appropriate omega-3 all help. Levels above 500 mg/dL are a separate clinical category that warrants working with a clinician.

What lowers high triglycerides most effectively?

For most people, the inputs the number is reading: less refined carbohydrate and added sugar, less alcohol, more movement, and weight reduction where relevant, often supported by omega-3-rich foods. Triglycerides are among the most responsive lines on a lipid panel, so these changes can move the number within weeks. A very high reading, or one that does not respond, warrants clinical evaluation rather than self-management alone.

Primary references from The Health Protocol bibliography

These papers are cited in the canonical bibliography of The Health Protocol. Full bibliography at thejourneybeginswithin.com/health/references/.

  1. [T1]Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heart disease in U.S. adults. Journal of the American College of Cardiology. 2017;70(4):411 to 422. The study distinguished healthful from unhealthful plant-based patterns and found sharply different coronary risk associations. TJBW [4.11]
  2. [T2]Koch M, Hjorth MF, Sjodin A, et al. Vegetarian or vegan diets and blood lipids: a meta-analysis of randomized trials. European Heart Journal. 2023;44(28):2609 to 2622. Vegetarian and vegan dietary patterns were associated with lower total cholesterol, low density lipoprotein cholesterol, and apolipoprotein B. TJBW [4.12]

Additional references cited in this article

All claims above are sourced to peer-reviewed literature. The numbered list below corresponds to the inline citations. The full bibliography for The Health Protocol is available at thejourneybeginswithin.com/health/references/.

  1. [1]Michael Miller et al.. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123(20):2292 to 2333. AHA scientific statement on triglycerides and cardiovascular risk: optimal fasting triglycerides below 100 mg/dL, with the triglyceride/HDL ratio as a useful proxy for insulin resistance. doi.org/10.1161/CIR.0b013e3182160726
  2. [2]Mohammad G. Saklayen. The global epidemic of the metabolic syndrome. Current Hypertension Reports. 2018;20(2):12. Review of the global prevalence of metabolic syndrome (estimated one-quarter of adults worldwide) and its components (visceral adiposity, dyslipidemia, hypertension, insulin resistance). doi.org/10.1007/s11906-018-0812-z
  3. [3]Michael J. Wilkinson et al.. Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metabolism. 2020;31(1):92 to 104.e5. Twelve-week trial of 10-hour time-restricted eating in patients with metabolic syndrome producing measurable reductions in weight, blood pressure, and atherogenic lipid markers. doi.org/10.1016/j.cmet.2019.11.004
  4. [4]Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. Journal of Clinical Investigation. 2009;119(5):1322 to 1334. Over ten weeks, fructose-sweetened but not glucose-sweetened beverages at 25 percent of energy raised de novo lipogenesis and visceral fat, promoted dyslipidemia, and reduced insulin sensitivity, despite similar weight gain. doi.org/10.1172/JCI37385
  5. [5]McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. 2003;139(10):802 to 809. A fasting triglyceride near 130 mg/dL and a triglyceride/HDL-cholesterol ratio near 3.0 identified insulin-resistant overweight adults with accuracy comparable to the full metabolic-syndrome criteria. doi.org/10.7326/0003-4819-139-10-200311180-00007
  6. [6]Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299 to 308. In a Copenhagen cohort of nearly 14,000 adults, elevated nonfasting triglycerides independently predicted myocardial infarction, ischemic heart disease, and death. doi.org/10.1001/jama.298.3.299
  7. [7]Sarwar N, Danesh J, Eiriksdottir G, et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation. 2007;115(4):450 to 458. Higher triglycerides were independently associated with coronary heart disease after adjustment for established risk factors, with adjusted odds ratios near 1.6 to 1.8. doi.org/10.1161/CIRCULATIONAHA.106.637793
  8. [8]Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. The Lancet. 2014;384(9943):626 to 635. A review of genetic and Mendelian-randomization evidence indicating that triglyceride-rich remnant lipoproteins are causally associated with cardiovascular disease, not merely a marker of it. doi.org/10.1016/S0140-6736(14)61177-6
  9. [9]Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation. 2019;140(12):e673 to e691. At 4 grams per day, prescription omega-3 lowers triglycerides by about 20 to 30 percent, and by more than 30 percent in severe hypertriglyceridemia, without raising LDL cholesterol. doi.org/10.1161/CIR.0000000000000709
  10. [10]Termannsen AD, Sondergaard CS, Faerch K, et al. Effects of plant-based diets on markers of insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials. Nutrients. 2024;16(13):2110. Plant-based dietary patterns improved fasting insulin and HOMA-IR in adults with overweight or obesity. doi.org/10.3390/nu16132110

Continue reading

Related from the Library.

Begin

From reading to implementation.

The Library teaches the framework. The seminar walks you through the implementation, six narrated modules paced over weeks instead of read in one sitting. Workbook included. Lifetime access. One payment of $245.

Enroll in the seminar →